APRI (Aprinoia Therapeutics) Scaled Net Operating Assets: -5.74 (As of Dec. 2023)


What is Aprinoia Therapeutics Scaled Net Operating Assets?

Aprinoia Therapeutics APRI Scaled Net Operating Assets is -5.74 as of Dec. 2023.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aprinoia Therapeutics's operating assets for the quarter that ended in Dec. 2023 was $3.37 Mil. Aprinoia Therapeutics's operating liabilities for the quarter that ended in Dec. 2023 was $86.45 Mil. Aprinoia Therapeutics's Total Assets for the quarter that ended in Jun. 2023 was $14.48 Mil. Therefore, Aprinoia Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was -5.74.

Aprinoia Therapeutics Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Scaled Net Operating Assets Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Scaled Net Operating Assets
-4.48 -5.79 -14.72

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Scaled Net Operating Assets -4.48 0.00 0.00 -13.13 -5.74

APRI vs : Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Aprinoia Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprinoia Therapeutics Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Scaled Net Operating Assets falls into.


Aprinoia Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aprinoia Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(3.368-86.447)/5.643
=-14.72

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4.946 - 1.578
=3.368

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=105.435 - 0.208 - 18.78
=86.447

Aprinoia Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Jun. 2023 )
=(3.368-86.447)/14.476
=-5.74

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4.946 - 1.578
=3.368

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=105.435 - 0.208 - 18.78
=86.447

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -5.74 mean?
Aprinoia Therapeutics (APRI) has a Scaled Net Operating Assets of -5.74 as of Dec. 2023. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Scaled Net Operating Assets too high?
Aprinoia Therapeutics' current Scaled Net Operating Assets is -5.74.
How does Aprinoia Therapeutics' Scaled Net Operating Assets compare to ?
Aprinoia Therapeutics' Scaled Net Operating Assets of -5.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Scaled Net Operating Assets is -5.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Scaled Net Operating Assets of -5.74. The current Scaled Net Operating Assets is -5.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Scaled Net Operating Assets is -5.74 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.